Shane Kovacs is the founder of Olema Oncology. Olema Oncology has raised $85M in total funding. Latest round: Series C. Based in San Francisco, United States.
Shane Kovacs is the Chief Operating and Financial Officer at Olema Oncology. The company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women's cancers. Olema Oncology recently raised $85 million in Series C financing to advance the clinical development of its lead product candidate, OP-1250, in breast cancer, and to expand ongoing research and development activities.
Full founder directory · Investor directory · Company funding database · Fundraising library